The Global Metagenomics Market: Fueled by Technological Advancement

The metagenomics market involves sequencing of genomes obtained directly from environmental samples containing unknown microbial organisms. Metagenomic techniques are used to identify microorganisms present in clinical or environmental samples without isolating or culturing them. This helps in discovering novel genetic elements and microbes from various ecosystems. The technique also allows large-scale analyses of complete genetic content present in microbial communities.
The metagenomics market is estimated to be valued at USD 2.18 Bn in 2024 and is expected to reach USD 3.77 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Key Takeaways

Key players operating in the metagenomics market: Key players operating in the metagenomics market are Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd, and PacBio.

Growing the market: The Metagenomics Market Size is witnessing high owing to the growing demand for identification of unknown pathogens, development of biofuels, and biomarker discovery. Metagenomics helps in understanding microbial diversity and provides comprehensive details on microbial communities.

Global expansion of the market: Key players in the metagenomics market are expanding their presence globally by partnering with research institutes and laboratories. The market is expected to grow at a high rate in emerging economies such as Asia Pacific and Latin America due to increasing R&D expenditures on metagenomics.
Get More Insights on- Metagenomics Market